2m 2m 2m 2m 2m 2m 2m
Starling Oncol (STLN)
NASDAQ
$3.62-$0.13 (-3.47%)
Price as of Nov 13, 2026 1:55 PM EST- $382.5MMarket Cap
- N/A1-Year Change
- Medical Care FacilitiesIndustry
Starling Oncol (STLN)
$3.62-$0.13 (-3.47%)
STLN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.75 | ||
Change | -$0.45 (-10.71%) | ||
Open | $4.10 | ||
High | $4.24 | ||
Low | $3.67 | ||
Previous Close | $4.20 | ||
Volume | 6,536,571 | ||
30-Day Average Volume | 3,168,290 | ||
1-Week Change | -44.03% | ||
1-Month Change | -45.81% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 102.0M | ||
Total Assets | $187.8M | ||
Market Cap | $382.5M | ||
Enterprise Value | $423.1M | ||
Period: QTR TTM FY | |||
Revenue | $60.0M | ||
Net Income | -$15.7M | ||
Free Cash Flow | $8.9M | ||
EBIT | -$15.7M | ||
EBITDA | -$14.2M | ||
Net Working Capital | $14.0M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -30 | ||
Enterprise Value/Revenue | 7 | ||
P/B | -10 | ||
P/E | -29 | ||
PEG | 0 | ||
Price/Free Cash Flow | 43 | ||
Price/Operating Cash Flow | 38 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue